Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs Amlodipine in Black Hypertensives with LSD1 Risk Allele
NCT04840342Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2022
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in hypertension (HTN), sponsored by Brigham and Women's Hospital. Started Feb 2022; status: completed.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04840342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840342.